Synopsys (SNPS) shares were down 5.2% in recent trading on Thursday after the company suspended its fiscal Q3 and fiscal year 2025 guidance.
The company said it received a letter from the Bureau of Industry and Security of the US Department of Commerce regarding new export restrictions to China.
"Synopsys is currently assessing the potential impact of the BIS letter on its business, operating results and financial condition," the company said in a statement.
Price: 438.37, Change: -24.06, Percent Change: -5.20